NCT05240898

URI: https://gptkb.org/entity/NCT05240898
GPTKB entity
Statements (19)
Predicate Object
gptkbp:instanceOf gptkb:clinical_trial
gptkbp:clinicalTrialPhase Phase 3
gptkbp:clinicalTrialsGovId gptkb:NCT05240898
gptkbp:conditionStudied gptkb:Alzheimer_Disease
gptkbp:estimatedEnrollment 3300
https://www.w3.org/2000/01/rdf-schema#label NCT05240898
gptkbp:intervention gptkb:Donanemab
gptkbp:location gptkb:Australia
gptkb:Canada
gptkb:Europe
gptkb:United_States
gptkbp:officialName gptkb:A_Study_of_Donanemab_(LY3002813)_in_Participants_With_Preclinical_Alzheimer’s_Disease_(TRAILBLAZER-ALZ_3)
gptkbp:primaryCompletionDate 2027-06-01
gptkbp:sponsor gptkb:Eli_Lilly_and_Company
gptkbp:startDate 2022-03-01
gptkbp:status Recruiting
gptkbp:studyType Interventional
gptkbp:bfsParent gptkb:KSQ-001EX
gptkbp:bfsLayer 6